CRISPR Therapeutics
(NASDAQ:CRSP)
$64.11
-0.52[-0.80%]
Last update: 10:45AM
Day Range63.38 - 65.7652 Wk Range42.51 - 86.95Open / Close64.44 / -Float / Outstanding67.4M / 78M
Vol / Avg.204.3K / 1.4MMkt Cap5BP/E-50d Avg. Price70.32
Div / Yield-Payout Ratio-Total Float67.4MEPS-2.4

CRISPR Therapeutics Stock (NASDAQ:CRSP), Quotes and News Summary

CRISPR Therapeutics Stock (NASDAQ: CRSP)

Day Range63.38 - 65.7652 Wk Range42.51 - 86.95Open / Close64.44 / -Float / Outstanding67.4M / 78M
Vol / Avg.204.3K / 1.4MMkt Cap5BP/E-50d Avg. Price70.32
Div / Yield-Payout Ratio-Total Float67.4MEPS-2.4
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-02
REV
Q2 2022Est.ActualSurprise
EPS-2.230-2.400 -0.1700
REV2.060M158.000K-1.902M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

CRISPR Therapeutics Questions & Answers

Q
How do I buy CRISPR Therapeutics (CRSP) stock?
A

You can purchase shares of CRISPR Therapeutics (NASDAQ: CRSP) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are CRISPR Therapeutics's (CRSP) competitors?
A

There are no as such competitors for CRISPR Therapeutics.

Q
What is the target price for CRISPR Therapeutics (CRSP) stock?
A

The latest price target for CRISPR Therapeutics (NASDAQ: CRSP) was reported by Credit Suisse on Tuesday, August 9, 2022. The analyst firm set a price target for 90.00 expecting CRSP to rise to within 12 months (a possible 40.38% upside). 32 analyst firms have reported ratings in the last year.

Q
Current Stock Price for CRISPR Therapeutics (CRSP)?
A

The stock price for CRISPR Therapeutics (NASDAQ: CRSP) is $64.11 last updated Today at October 6, 2022, 2:45 PM UTC.

Q
Does CRISPR Therapeutics (CRSP) pay a dividend?
A

There are no upcoming dividends for CRISPR Therapeutics.

Q
When is CRISPR Therapeutics (NASDAQ:CRSP) reporting earnings?
A

CRISPR Therapeutics’s Q3 earnings are confirmed for Wednesday, November 2, 2022.

Q
Is CRISPR Therapeutics (CRSP) going to split?
A

There is no upcoming split for CRISPR Therapeutics.

Q
What sector and industry does CRISPR Therapeutics (CRSP) operate in?
A

CRISPR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.